Karp Capital Management Corp Bristol Myers Squibb CO Transaction History

Karp Capital Management Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $3.05 Million - $3.43 Million	-51,455 Closed	0 $0
Q4 2020 Feb 05, 2021	BUY	$57.74 - $65.43 $142,155 - $161,088	2,462 Added 5.03%	51,455 $3.19 Million
Q3 2020 Nov 12, 2020	BUY	$57.43 - $63.64 $319,942 - $354,538	5,571 Added 12.83%	48,993 $2.95 Million
Q2 2020 Aug 04, 2020	BUY	$54.82 - $64.09 $105,638 - $123,501	1,927 Added 4.64%	43,422 $2.55 Million
Q1 2020 May 14, 2020	BUY	$46.4 - $67.43 $106,024 - $154,077	2,285 Added 5.83%	41,495 $2.31 Million
Q4 2019 Feb 10, 2020	BUY	$49.21 - $64.19 $1.93 Million - $2.52 Million	39,210 New	39,210 $2.52 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Karp Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Karp Capital Management Corp with notifications on news.